The effect of fenofibrate on plasma and HDL levels of PAF-acetylhydrolase: <br /> A new modulating action of the fibrates?
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2004, Vol 21, Issue 1
Abstract
OBJECTIVE Human plasma platelet activating factor acetylhydrolase (PAF-AH) is an enzyme associated mainly with the apolipoprotein B-containing lipoproteins. A small proportion of circulating enzyme activity is also associated with high-density lipoprotein (HDL). Plasma paraoxonase 1 (PON-1) is an esterase exclusively associated with HDL. METHOD The effect of micronized fenofibrate (200 mg per day for 3 months) on PAFAH and PON-1 activities in patients with dyslipidemia of types IIA (n=18), IIB (n=23) and IV (n=30) was studied. RESULTS Fenofibrate significantly reduced plasma PAF-AH activity in all patient groups. In type IIA patients this was mainly due to a fall in enzyme activity associated with the dense LDL subspecies, whereas in types IIB and IV patients the reduction was due to the decrease in PAF-AH activity associated with both the VLDL+IDL and dense LDL subspecies. Drug therapy in type IIB and type IV patients significantly increased the HDL-associated PAF-AH activity due to the induction in enzyme activity associated with the HDL3c subfraction. Fenofibrate therapy did not affect either total serum PON-1 action on paraoxon and phenylacetate or the enzyme activities associated with the HDL subfractions, in either patient group. CONCLUSIONS The fenofibrate- induced elevation of HDL-associated PAF-AH activity in dyslipidemic patients of type IIB and type IV and the reduction in enzyme activity associated with atherogenic apoB-containing lipoproteins in these patient groups as well as in type IIA patients, may represent a new and important overall anti-atherogenic effect of this potent lipid-modulating agent
Authors and Affiliations
V. TSIMIHODIMOS, A. KAKAFIKA, H. BAIRACHTARI, M. ELISAF
Acute monoblastic leukaemia-leukaemia cutis after progression of refractory anemia with ringed sideroblasts and multilineage<br /> dysplasia.
Co-administration of vasopressin-levosimendan improves survival in a swine model of ventricular fibrillation
OBJECTIVE It was hypothesized that the co-administration of vasopressin and levosimendan during cardiopulmonary resuscitation would improve survival and neurological outcome in comparison to the administration of vasopre...
FROM THE NEW EDITOR
No abstract available
Standardization
Standardization is a method of controlling the confounding introduced by different age distributions in two or more compared groups. It is a method of combining category-specific rates into a single summary value by ta...
Selective targeting of transcription factors in neoplasia
No abstract available